Liposomal form of lipoic acid: preparation and determination of antiplatelet and antioxidant activity

   
Shchelkonogov V.A.1, Sorokoumova G.M.1 , Baranova O.A.2, Chekanov A.V.2, Klochkova A.V.2, Kazarinov K.D.3, Solovieva E.Y.2, Fedin A.I.2, Shvets V.I.1

1. Moscow technological University (MITHT), Moscow, Russia
2. Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia
3. Kotelnikov Institute of Radioengineering and Electronics, (Fryasino branch), Fryazino, Moscow region, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20166205577      PubMed Id: 27797334
Year: 2016  Volume: 62  Issue: 5  Pages: 577-583
Optimal conditions for obtaining phosphatidylholine (PC) liposomes with lipoic acid (LA) are chosen that lead to the formation of nanoparticles with a size of 175¸284 nm with efficiency (extent) of inclusion of LA in liposomes equal 85% and characterized by a slow release of substance from the nanoparticles. The effect of “empty” liposomes and liposomal form of LA on platelet aggregation induced by arachidonic acid (AA) is established. It is found that liposomes with LА inhibit platelet aggregation, caused by AА, to 80%. In addition, it is shown that “empty” liposomes slightly (to 30%) suppress platelet aggregation, caused by AА. The amount of TBA-sensitive products in samples of platelet-rich plasma (PRP) incubated with liposomal LA is determined. It is shown that LA in the composition of liposomes retains its antioxidant properties, and the amount of products of lipid peroxidation in platelet-rich plasma decreases in a dose-dependent manner when arachidonic acid is used as an inductor of platelet aggregation. It is assumed that the antiplatelet action of the liposomal form of LА is induced by inhibition of the initiation of lipid peroxidation products caused by exogenous inducer AА. It is supposed that, after additional research, the liposomal form of LA can be considered as a new drug in complex treatment of cerebral ischemia.
Download PDF:  
Keywords: liposomes, lipoic acid, platelet, arachidonic acid
Citation:

Shchelkonogov, V. A., Sorokoumova, G. M., Baranova, O. A., Chekanov, A. V., Klochkova, A. V., Kazarinov, K. D., Solovieva, E. Y., Fedin, A. I., Shvets, V. I. (2016). Liposomal form of lipoic acid: preparation and determination of antiplatelet and antioxidant activity. Biomeditsinskaya Khimiya, 62(5), 577-583.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)